2-25388313-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021907.5(DTNB):c.1624C>T(p.Arg542Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,613,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
DTNB
NM_021907.5 missense
NM_021907.5 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 6.48
Genes affected
DTNB (HGNC:3058): (dystrobrevin beta) This gene encodes dystrobrevin beta, a component of the dystrophin-associated protein complex (DPC). The DPC consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and dystrobrevin alpha and beta. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Dystrobrevin beta is thought to interact with syntrophin and the DP71 short form of dystrophin. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1960639).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DTNB | NM_021907.5 | c.1624C>T | p.Arg542Trp | missense_variant | 17/21 | ENST00000406818.8 | NP_068707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DTNB | ENST00000406818.8 | c.1624C>T | p.Arg542Trp | missense_variant | 17/21 | 1 | NM_021907.5 | ENSP00000384084.3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152268Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
10
AN:
152268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000323 AC: 8AN: 247884Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134518
GnomAD3 exomes
AF:
AC:
8
AN:
247884
Hom.:
AF XY:
AC XY:
1
AN XY:
134518
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460902Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726626
GnomAD4 exome
AF:
AC:
25
AN:
1460902
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
726626
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152386Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74522
GnomAD4 genome
AF:
AC:
10
AN:
152386
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2024 | The c.1624C>T (p.R542W) alteration is located in exon 17 (coding exon 16) of the DTNB gene. This alteration results from a C to T substitution at nucleotide position 1624, causing the arginine (R) at amino acid position 542 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;D;.;.;.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;L;.;.;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;.;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;.;D
Sift4G
Uncertain
D;D;T;D;T;D;D;D
Polyphen
1.0, 1.0, 1.0, 0.99
.;D;D;.;D;.;.;D
Vest4
MVP
MPC
0.30
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at